JP2022518148A5 - - Google Patents

Info

Publication number
JP2022518148A5
JP2022518148A5 JP2021539166A JP2021539166A JP2022518148A5 JP 2022518148 A5 JP2022518148 A5 JP 2022518148A5 JP 2021539166 A JP2021539166 A JP 2021539166A JP 2021539166 A JP2021539166 A JP 2021539166A JP 2022518148 A5 JP2022518148 A5 JP 2022518148A5
Authority
JP
Japan
Prior art keywords
pyrimidine
methylbenzofl
carboxylic acid
pyrrolidine
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021539166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518148A (ja
JP7507161B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/012243 external-priority patent/WO2020142729A1/en
Publication of JP2022518148A publication Critical patent/JP2022518148A/ja
Publication of JP2022518148A5 publication Critical patent/JP2022518148A5/ja
Application granted granted Critical
Publication of JP7507161B2 publication Critical patent/JP7507161B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539166A 2019-01-04 2020-01-03 治療薬としてのcGAS活性の阻害剤 Active JP7507161B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962788624P 2019-01-04 2019-01-04
US62/788,624 2019-01-04
PCT/US2020/012243 WO2020142729A1 (en) 2019-01-04 2020-01-03 Inhibitors of cgas activity as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2022518148A JP2022518148A (ja) 2022-03-14
JP2022518148A5 true JP2022518148A5 (cg-RX-API-DMAC7.html) 2023-03-06
JP7507161B2 JP7507161B2 (ja) 2024-06-27

Family

ID=72338800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021539166A Active JP7507161B2 (ja) 2019-01-04 2020-01-03 治療薬としてのcGAS活性の阻害剤

Country Status (8)

Country Link
US (1) US20220073532A1 (cg-RX-API-DMAC7.html)
EP (1) EP3906241A4 (cg-RX-API-DMAC7.html)
JP (1) JP7507161B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210112316A (cg-RX-API-DMAC7.html)
CN (1) CN113302194A (cg-RX-API-DMAC7.html)
AU (1) AU2020205114A1 (cg-RX-API-DMAC7.html)
CA (1) CA3125625A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020142729A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4216940A4 (en) * 2020-09-24 2025-01-01 Ventus Therapeutics U.S., Inc. PYRIDO[4,3-B INDOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS
CN116997339A (zh) * 2021-02-11 2023-11-03 贝尔布鲁克实验室有限责任公司 作为治疗剂的cGAS活性抑制剂
BR112023020381A2 (pt) 2021-05-12 2023-11-21 Boehringer Ingelheim Int Derivados de piridina com substituintes cíclicos ligados por c como inibidores de cgas
CN117337292A (zh) * 2021-05-12 2024-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的具有N-连接环状取代基的吡啶衍生物
CN117337291A (zh) * 2021-05-12 2024-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的具有C-连接环状取代基的吡啶衍生物
WO2024035622A1 (en) * 2022-08-10 2024-02-15 Bellbrook Labs, Llc INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS
CA3267076A1 (en) * 2022-11-09 2024-05-16 Boehringer Ingelheim International Gmbh CYCLIC PYRIDINE DERIVATIVES USED AS CGAS INHIBITORS
CN121248633A (zh) * 2022-11-09 2026-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的环状苯并咪唑衍生物
US20250257076A1 (en) 2024-02-14 2025-08-14 Janssen Pharmaceutica Nv SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS
WO2025233174A1 (en) 2024-05-08 2025-11-13 Boehringer Ingelheim International Gmbh Benzimidazole derivatives as cgas inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755583A (en) * 1970-06-05 1973-08-28 Chas0!nhx
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
EP1812113A1 (en) * 2004-11-11 2007-08-01 Argenta Discovery Limited Pyrimidine compounds as histamine modulators
EP1767537A1 (en) 2005-09-21 2007-03-28 Cellzome (UK) Ltd. Pyrimidine compounds for the treatment of inflammatory disorders
ES2441958T3 (es) * 2006-07-11 2014-02-07 Janssen Pharmaceutica Nv Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
GB2465405A (en) * 2008-11-10 2010-05-19 Univ Basel Triazine, pyrimidine and pyridine analogues and their use in therapy
WO2013115167A1 (ja) 2012-01-31 2013-08-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 アムバチニブ誘導体
CN104513258B (zh) * 2013-09-26 2018-04-03 广东东阳光药业有限公司 取代脲衍生物及其在药物中的应用
KR20250065420A (ko) * 2015-12-25 2025-05-12 가부시키가이샤 한도오따이 에네루기 켄큐쇼 화합물, 발광 소자, 표시 장치, 전자 기기, 및 조명 장치
EP3700527A4 (en) * 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHOD OF USING THEM

Similar Documents

Publication Publication Date Title
JP7317878B2 (ja) 多環式tlr7/8アンタゴニスト及び免疫障害の治療におけるそれらの使用
JP6505013B2 (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP4724665B2 (ja) キノリノン化合物を合成する方法
JP6517928B2 (ja) キナーゼ阻害剤として有用なインドールカルボキシアミド
JP2024506904A5 (cg-RX-API-DMAC7.html)
TWI583681B (zh) 胺基嘧啶基化合物
CN109641906B (zh) 杂芳基取代的氨基吡啶化合物
CN114787150A (zh) 炔基喹唑啉化合物
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2010506854A5 (cg-RX-API-DMAC7.html)
TW201925187A (zh) 經碸吡啶烷基醯胺取代之雜芳基化合物
JP2012503018A5 (cg-RX-API-DMAC7.html)
JP2007510668A5 (cg-RX-API-DMAC7.html)
JP2018514544A5 (cg-RX-API-DMAC7.html)
CN115485026A (zh) Nlrp3炎体途径抑制剂吡唑并[1,2-d][1,2,4]三嗪-2-基-乙酰胺
JP2016527238A5 (cg-RX-API-DMAC7.html)
JP2005530722A5 (cg-RX-API-DMAC7.html)
WO2008064116A2 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
CA2682649A1 (en) Imidazolidine carboxamide derivatives as p2x7 modulators
CA2557271A1 (en) 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
JP2023554442A (ja) 新規キナゾリノン誘導体
TR201901074T4 (tr) MGlu2 reseptörlerinin negatif allosterik modülatörleri olarak 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-on bileşikleri ve bunların kullanımı.
JP2021536505A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2017534569A5 (cg-RX-API-DMAC7.html)